Institution
University of Marburg
Education•Marburg, Germany•
About: University of Marburg is a education organization based out in Marburg, Germany. It is known for research contribution in the topics: Population & Gene. The organization has 23195 authors who have published 42907 publications receiving 1506069 citations. The organization is also known as: Philipps University of Marburg & Philipps-Universität.
Topics: Population, Gene, Crystal structure, Laser, Catalysis
Papers published on a yearly basis
Papers
More filters
••
University of Marburg1, Goethe University Frankfurt2, University Medical Center Freiburg3, University of Münster4, Dresden University of Technology5, University of Hamburg6, Technische Universität München7, Augsburg College8, RWTH Aachen University9, Innsbruck Medical University10, University of Tübingen11, Ludwig Maximilian University of Munich12, University of Mainz13
TL;DR: Exploratory data show that patients with undetectable minimal residual disease (MRD) before HCT and those with detectable MRD after HCT derive the strongest benefit from sorafenib, and maintenance therapy reduces the risk of relapse and death after H CT for FLT3-ITD-positive AML.
Abstract: PURPOSEDespite undergoing allogeneic hematopoietic stem cell transplantation (HCT), patients with acute myeloid leukemia (AML) with internal tandem duplication mutation in the FMS-like tyrosine kin...
273 citations
••
TL;DR: Growing evidence suggests that proteins may contribute directly to the spliceosome's active sites.
273 citations
••
TL;DR: Four years after stroke, besides physical functioning, neuropsychological sequelae such as depression and cognitive impairment contributed to a reduced HRQoL, and the incidence of incontinence proved to be an important factor for HRZoL.
Abstract: Background and Purpose— As stroke mortality rates decline, individuals are increasingly likely to live with their residual impairments and disabilities. Therefore, the quality of poststroke life is...
272 citations
••
German Center for Neurodegenerative Diseases1, University of Marburg2, Technische Universität München3, National and Kapodistrian University of Athens4, University of Saskatchewan5, Erasmus University Rotterdam6, King's College London7, University of Barcelona8, Ludwig Maximilian University of Munich9
TL;DR: The phenotypic spectrum of progressive supranuclear palsy may be broader and more variable than previously described in single‐center studies, and too strict clinical criteria defining distinct phenotypes may not reflect this variability.
Abstract: The phenotypic variability of progressive supranuclear palsy (PSP) may account for its frequent misdiagnosis, in particular in early stages of the disease. However, large multicenter studies to define the frequency and natural history of PSP phenotypes are missing. In a cohort of 100 autopsy-confirmed patients we studied the phenotypic spectrum of PSP by retrospective chart review. Patients were derived from five brain banks with expertise in neurodegenerative disorders with referrals from multiple academic hospitals. The clinical characteristics of the 100 cases showed remarkable heterogeneity. Most strikingly, only 24% of cases presented as Richardson's Syndrome (RS), and more than half of the cases either showed overlapping features of several predescribed phenotypes, or features not fitting proposed classification criteria for PSP phenotypes. Classification of patients according to predominant clinical features in the first 2 years of the disease course allowed a more comprehensive description of the phenotypic spectrum. These predominance types differed significantly with regard to survival time and frequency of cognitive deficits. In summary, the phenotypic spectrum of PSP may be broader and more variable than previously described in single-center studies. Thus, too strict clinical criteria defining distinct phenotypes may not reflect this variability. A more pragmatic clinical approach using predominance types could potentially be more helpful in the early recognition of and for making prognostic predictions for these patients. Given the limitations arising from the retrospective nature of this analysis, a systematic validation in a prospective cohort study is imperative.
272 citations
••
TL;DR: Improvements in grid technology, surgical technique, and postoperative care resulted in significant reductions in the complication rate, and no association with complications was found for number of seizures, IQ, anticonvulsants, or grid localization.
Abstract: Objective: To evaluate the risk factors, type, and frequency of complications during video-EEG monitoring with subdural grid electrodes. Methods: The authors retrospectively reviewed the records of all patients who underwent invasive monitoring with subdural grid electrodes (n = 198 monitoring sessions on 187 patients; median age: 24 years; range: 1 to 50 years) at the Cleveland Clinic Foundation from 1980 to 1997. Results: From 1980 to 1997, the complication rate decreased ( p = 0.003). In the last 5 years, 19/99 patients (19%) had complications, including two patients (2%) with permanent sequelae. In the last 3 years, the complication rate was 13.5% (n = 5/37) without permanent deficits. Overall, complications occurred during 52 monitoring sessions (26.3%): infection (n = 24; 12.1%), transient neurologic deficit (n = 22; 11.1%), epidural hematoma (n = 5; 2.5%), increased intracranial pressure (n = 5; 2.5%), and infarction (n = 3; 1.5%). One patient (0.5%) died during grid insertion. Complication occurrence was associated with greater number of grids/electrodes ( p = 0.021/ p = 0.052; especially >60 electrodes), longer duration of monitoring ( p = 0.004; especially >10 days), older age of the patient ( p = 0.005), left-sided grid insertion ( p = 0.01), and burr holes in addition to the craniotomy ( p = 0.022). No association with complications was found for number of seizures, IQ, anticonvulsants, or grid localization. Conclusions: Invasive monitoring with grid electrodes was associated with significant complications. Most of them were transient. Increased complication rates were related to left-sided grid insertion and longer monitoring with a greater number of electrodes (especially more than 60 electrodes). Improvements in grid technology, surgical technique, and postoperative care resulted in significant reductions in the complication rate.
272 citations
Authors
Showing all 23488 results
Name | H-index | Papers | Citations |
---|---|---|---|
John C. Morris | 183 | 1441 | 168413 |
Russel J. Reiter | 169 | 1646 | 121010 |
Martin J. Blaser | 147 | 820 | 104104 |
Christopher T. Walsh | 139 | 819 | 74314 |
Markus Cristinziani | 131 | 1140 | 84538 |
James C. Paulson | 126 | 443 | 52152 |
Markus F. Neurath | 124 | 934 | 62376 |
Nicholas W. Wood | 123 | 614 | 66270 |
Florian Lang | 116 | 1421 | 66496 |
Howard I. Maibach | 116 | 1821 | 60765 |
Thomas G. Ksiazek | 113 | 398 | 46108 |
Frank Glorius | 113 | 663 | 49305 |
Eberhard Ritz | 111 | 1109 | 61530 |
Manfred T. Reetz | 110 | 959 | 42941 |
Wolfgang H. Oertel | 110 | 653 | 51147 |